Syneos Health to Present at Upcoming Investor Conferences
MORRISVILLE, N.C., May 22, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq: SYNH) announced that CEO Alistair Macdonald and CFO Jason Meggs will present at two investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MORRISVILLE, N.C., May 22, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq: SYNH) announced that CEO Alistair Macdonald and CFO Jason Meggs will present at two investor conferences. The events are the Jefferies Virtual Healthcare Conference on June 3, 2020, at 9:30 a.m. ET, and the William Blair 40th Annual Growth Stock Conference on June 9, 2020, at 9:00 a.m. ET. Live webcasts and presentation materials will be available on the Company’s Investor Relations website.
Syneos Health is a fully integrated biopharmaceutical solutions organization, combining a CRO and CCO.
Details
News Market Reaction – SYNH
The recorded move for SYNH in the trading session of this news was +0.30%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MORRISVILLE, N.C., May 22, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs are scheduled to present at two upcoming investor conferences:
- Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020, at 9:30 a.m. ET.
- William Blair 40th Annual Growth Stock Conference on Tuesday, June 9, 2020, at 9:00 a.m. ET.
A live webcast of each event, along with a link to the presentation materials and archived audio replay of each presentation, will be available on the Company’s Investor Relations website at investor.syneoshealth.com.
About Syneos Health
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
Contacts
Investor Relations:
Ronnie Speight
Senior Vice President, Investor Relations
+1 919 745 2745
Investor.Relations@syneoshealth.com
Press/Media:
Danielle DeForge
Executive Director, External Communications
+1 202 210 5992
danielle.deforge@syneoshealth.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.